Cardiovasculer Diseases and Microbiota

Main Article Content

Perihan Varım Mehmet Bülent Vatan Ceyhun Varım

Abstract

Cardiovascular Diseases (CVD) are the most common cause of death in worldwide It accounts for 31% of all deaths in the world. Risk factors for CVD are smoking, unhealthy diet, obesity, physical inactivity, high blood pressure (hypertension), high blood fat and diabetes.


Bacteria that have been settled in various parts of the body such as skin, mouth, vagina, intestines are called “floras”, new name is called “microbiota”. The genome of microorganisms is called “ microbiome “ The human body is composed of 10% of its own cells and 90% of the existing microbial cells.Intestinal microbiota; carries out very important tasks on the physiological, metabolic and immunological systems in our body.Intestinal bacteria that control the necessary metabolic processes by assuming the role of energy carrier or releasing immunomodulating substances because of this it is now defi ned as a new “metabolic organ”. Recent studies with intestinal microbiology have shown that microbiota is associated with both metabolic and cardiovascular diseases.


Intestinal microbiota associated with many diseases has made it possible to use microbiota modifi cation in therapy. The modifi cation of the intestinal microbiota with products like probiotic, prebiotic and symbiotic becomes increasingly important treatment method.

Article Details

How to Cite
VARIM, Perihan; VATAN, Mehmet Bülent; VARIM, Ceyhun. Cardiovasculer Diseases and Microbiota. Journal of Biotechnology and Strategic Health Research, [S.l.], v. 1, p. 141-147, dec. 2017. Available at: <http://biotechealthresearch.com/index.php/bio/article/view/44>. Date accessed: 21 apr. 2019.
Section
Articles